2010-06-28
Norwegian Microdialysis study awarded with prestigious award
At the 16th annual ILTS meeting in Hong Kong www.ilts.org, Professor Tor-Inge Tønnessen and his team from Rikshospitalet, Oslo, Norway were awarded with the prestigious Rising Star Award for their abstract “Monitoring Metabolic Parameters in Liver Transplants with Microdialysis Detects Vascular Disturbances and Rejection”.
The aim of the project was to find new and improved methods for monitoring transplanted livers. Despite improvements in the last decades vascular complications occur in 3-12 % following orthotopic liver transplantation. The project is the largest published study of its kind and included more than 70 patients.
The study concluded that intrahepatic measurement of metabolic parameters by using microdialysis can detect hepatic artery occlusion very rapidly. Metabolic and inflammatory markers detected rejection up to three days before conventional blood sample analysis. During rejection a significant moderate increase in lactate and significant but small increases in glycerol and glucose was observed.
CMA congratulates Professor Tønnessen and his team!
|
2010-06-25
CMA offers OEM and production services to the medical device market
CMA is now offering OEM production services for any type of customer in need to world-class Clean Room and Regulatory capabilities. As one of very few companies in Sweden with Class III medical devices, CMA runs a world-class factory serving customers across the globe. By combining the resources of our internal production and utilizing existing infrastructure and certifications, CMA is now expanding the services to also offer cost-effective production services.
For more info, see here
|
2010-06-24
CMA supports Multimodalmonitoring.org – a new web cooperation project organized by the Karolinska Institute
The new website www.multimodalmonitoring.org is a companion to CMA’s ICUpilot software, which collects data from bedside monitors and makes use of powerful graphics to uncover relationships between the recorded variables. In this way multimodal data can be related to therapeutic interventions in order to increase knowledge, improve quality and eventually prove or disprove patient benefits.
Professor Urban Ungerstedt runs the website and community and launched the project in June through presentations in Chicago and Frankfurt. Over 65 doctors from leading hospitals across Europe and US attended. The goal of the project is to use a common website to share multimodal monitoring data between ICU’s in different countries.
The project is completely separated from CMA and financed through the Karolinska Institute and other research grants. CMA contributes by offering members of the community free access to the ICUpilot software that enables collection of multimodal monitoring data.
|
2010-05-25
CMA enters into translational Alzheimer research project
Uppsala Berzelii Technology Centre for Neurodiagnostics is a centre of excellence with the overall goal to enable early diagnosis of neurodegenerative diseases, in particular Alzheimer’s disease and chronic pain, by identifying and validating relevant biomarkers. Eventually, such biomarkers can also aid in the development of new and better therapies. The mission is to identify and validate diagnostic and prognostic biomarkers in the field of neurorelated diseases, by bringing together key players from care givers, academia and biotechnology industry. This will be accomplished by a unique platform for translational research uniting patient care, basic and clinical research, and health care industry expertise.
What makes this Centre unique in an international perspective is the close connection and proximity between on one hand clinical research groups with access to large sets of biomaterial (public sector) and on the other technology-driven research groups (academia) tailoring new assays for the clinicians. In addition, several industrial partners, including CMA, bring in valuable resources and knowledge, and are well suited for bringing forward new products based on the findings from the Centre.
On June 8th, 2010, an open seminar about Chronic Pain- and Alzheimer's Disease research will be arranged by Uppsala Berzelii Centre in Uppsala, Sweden. The seminar will be in Swedish. See invitation here.
For more info on the Berzelii Center, see their website here.
|
2010-04-15
CMA upgrades the standard of microdialysis with β-irradiated probes
In response to customer requests, CMA is proud to launch probes that are β-irradiated for use in experiments where it is essential to minimize contamination by pathogens.
Initially it will be the CMA 7 probes and guides that will be available in April by a customer order. Remember, all CMA microdialysis probes are manufactured in a controlled clean environment under ISO 13485 standard.
Note: These probes are β-irradiated, but are not for human use.
|
